Literature DB >> 18448150

An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation.

Xiangfeng Li1, Takehisa Iwai, Hiroaki Nakamura, Yoshinori Inoue, Yiwen Chen, Makoto Umeda, Hidenori Suzuki.   

Abstract

One of the major pathogens of periodontitis, Porphyromonas gingivalis (P. gingivalis), has the ability to aggregate human platelets. To investigate the interaction between P. gingivalis and human platelets in platelet rich plasma (PRP), platelet aggregation was measured by an aggregometer based on laser light scattering (LS) methods, and an ultrastructural study was performed using electron microscopy. A sharp and rapid increase of small-sized platelet aggregates was observed immediately after the addition of P. gingivalis to PRP, followed by the formation of medium- and large-sized aggregates in 2-3 min. In contrast, when Staphylococcus aureus (S. aureus) was used in the control experiment, only a slight increase in small-sized aggregates was detected. By electron microscopy, discoid-shaped platelets were observed prior to adding P. gingivalis. By 5 min after the addition of the bacteria, enormous platelet aggregates were observable. Most of the P. gingivalis were present between the adherent platelets, while some were internalized in platelet engulfment vacuoles. In contrast, when washed platelets were incubated with the bacteria under a non-stirring condition to prevent platelet aggregation, and stained with ruthenium red (RR) as an electron dense tracer of the cell surface including the open canalicular system (OCS), both RR-positive and -negative vacuoles containing P. gingivalis were identified in the activated platelets. Thus, this observation suggests that P. gingivalis residing in the RR-negative vacuoles is incorporated into the platelet cytoplasm by phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448150     DOI: 10.1016/j.thromres.2008.03.011

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  16 in total

1.  Differential detection rate of periodontopathic bacteria in atherosclerosis.

Authors:  Takahiro Toyofuku; Yoshinori Inoue; Nobuhisa Kurihara; Toshifumi Kudo; Masatoshi Jibiki; Norihide Sugano; Makoto Umeda; Yuichi Izumi
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549

2.  An Experimental Model of Peripheral Vascular Disease Involving the Intravenous Injection of Oral Bacteria.

Authors:  Kimihiro Igari; Yoshinori Inoue; Takehisa Iwai
Journal:  Ann Vasc Dis       Date:  2016-09-26

Review 3.  Pharmacological treatment for Buerger's disease.

Authors:  Daniel G Cacione; Cristiane R Macedo; Jose C C Baptista-Silva
Journal:  Cochrane Database Syst Rev       Date:  2016-03-11

Review 4.  The ins and outs of endocytic trafficking in platelet functions.

Authors:  Meenakshi Banerjee; Sidney W Whiteheart
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

5.  Platelets Endocytose Viral Particles and Are Activated via TLR (Toll-Like Receptor) Signaling.

Authors:  Meenakshi Banerjee; Yunjie Huang; Smita Joshi; Gabriel J Popa; Michael D Mendenhall; Qing Jun Wang; Beth A Garvy; Thein Myint; Sidney W Whiteheart
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-21       Impact factor: 8.311

6.  Are There Any Objections against Our Hypothesis That Buerger Disease Is an Infectious Disease?

Authors:  Takehisa Iwai; Makoto Umeda; Yoshinori Inoue
Journal:  Ann Vasc Dis       Date:  2012

7.  Buerger disease, smoking, and periodontitis.

Authors:  Takehisa Iwai; Yoshinori Inoue; Makoto Umeda
Journal:  Ann Vasc Dis       Date:  2008-10-24

8.  Clinical Study of Phlebitis Migrans and Incompetence of the Leg's Superficial Vein in Buerger Disease.

Authors:  Takehisa Iwai; Hiroko Kume; Yoshinori Inoue; Makoto Umeda; Tomoko Kagayama; Masayuki Hirokawa
Journal:  Ann Vasc Dis       Date:  2012-02-15

9.  The thrombotic potential of oral pathogens.

Authors:  Steven W Kerrigan; Dermot Cox
Journal:  J Oral Microbiol       Date:  2009-08-26       Impact factor: 5.474

10.  Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).

Authors:  Daniel G Cacione; Frederico do Carmo Novaes; Daniel H Moreno
Journal:  Cochrane Database Syst Rev       Date:  2018-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.